Vanda Pharmaceuticals | VNDA - Öz Sermaye Ve Yedekler





Öz Sermaye Ve Yedekler Değişiklik Tarih
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 613.98M 45.56M 2026-03
AstraZeneca USD 50.3B 2.96B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Insmed USD 704.85M 34.12M 2026-03
J&J USD 84.97B 3.78B 2026-06
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Merck USD 45.88B 6.73B 2026-03
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Moderna USD 6.76B 647M 2026-06
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 69.57B 3.24B 2026-06
Takeda JPY 7.56T 215.7B 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Veracyte USD 1.39B 44M 2026-06